Atrial fibrillation ablation
Transcatheter ablation can be used in case of atrial fibrillation (AF) not controlled by medical therapy due to lack of efficacy or poor tolerability.The procedure is however associated with the risk of periprocedural events and therefore requires particular attention to systemic anticoagulant ther...
Main Author: | Giuseppe Sgarito |
---|---|
Format: | Article |
Language: | English |
Published: |
AboutScience Srl
2018-09-01
|
Series: | AboutOpen |
Subjects: | |
Online Access: | https://journals.aboutscience.eu/index.php/aboutopen/article/view/142 |
Similar Items
-
Dabigatran in the ischemic patient undergoing atrial fibrillation ablation
by: Roberto Spoladore
Published: (2018-10-01) -
Nationwide survey of catheter ablation for atrial fibrillation: The Japanese catheter ablation registry of atrial fibrillation (J-CARAF)–A report on periprocedural oral anticoagulants
by: Yuji Murakawa, MD, et al.
Published: (2015-02-01) -
Non-stop dabigatran
by: Gianluca Manzo
Published: (2018-10-01) -
The fate of patients after failed epicardial ablation of atrial fibrillation
by: Giuseppe Nasso, et al.
Published: (2021-09-01) -
Catheter, surgical, or hybrid procedure: what future for atrial fibrillation ablation?
by: Giuseppe Nasso, et al.
Published: (2021-06-01)